LCF9: Lung Adenocarcinoma

Curie Institute - Lung Cancer


Related Models
PDX model Engraftment
Host Strain Name Site Type Material Material Status Passage
Not Specified Not Specified Not Specified Not Specified Not Specified 16
Swiss Nude interscapular fat pad Heterotopic Tissue fragment Not Specified 16, 18, 3, 5
Model Quality Control
Technique Description Passage
Fingerprinting high concordance between xenograft and patient tumor 18
Histology high concordance between xenograft and patient tumour 3
Publications
Title Sensitization Of EGFR Wild-Type Non-Small Cell Lung Cancer Cells To EGFR-Tyrosine Kinase Inhibitor Erlotinib.
Authors Raimbourg J, Joalland MP, Cabart M ... Lalier L.
Publication year 2017
Journal Sensitization of EGFR Wild-Type Non-Small Cell Lung Cancer Cells to EGFR-Tyrosine Kinase Inhibitor Erlotinib.
Patient
Sex Male
Race / Ethnicity Not specified / Not Specified
Derived Model LCF9
Patient Tumor Collection For PDX Model
Collection (Current Model)
Age 65
Diagnosis Lung Adenocarcinoma
Type primary
PDX Mouse LCF9
Collection Site Lung
Grade Not specified
Stage T2,N1 ( Classification: TNM staging system 2004)
Sample ID Sample Type Engrafted Tumor Passage Data Type Data Available Platform Used Raw Data
LCF9p5:03/09/2009 Engrafted Tumor Passage 5 cytogenetics Data is not available in the Finder FISH Not Available
LCF9p16:19/05/2015 Engrafted Tumor Passage 16 copy number alteration Data is not available in the Finder CGH array Not Available
LCF9p16:19/05/2015 Engrafted Tumor Passage 16 mutation Data is not available in the Finder Targeted NGS Not Available
LCF9p16:19/05/2015 Engrafted Tumor Passage 16 copy number alteration View data Not Available
LCF9p16:19/05/2015 Engrafted Tumor Passage 16 mutation View data Targeted NGS Not Available

Sample ID:     Histology:     Tumor Type: Engrafted Tumor     Passage:     Platform: